Skip to content

Cingulate Inc.: 10-Q filed 2025-11-13

What Cingulate Inc. reported in its quarterly report filed 2025-11-13 (fiscal Q3 2025): 34 published measures, 100 facts as tagged in accession 0001493152-25-022395.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-13
Fiscal period
fiscal Q3 2025
Accession
0001493152-25-022395 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cingulate Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3010,518,892USD
At 2024-12-3114,864,489USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-307,045,206USD
At 2024-12-317,408,984USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-303,473,686USD
At 2025-06-305,511,874USD
At 2025-03-315,930,820USD
At 2024-12-317,455,505USD
At 2024-09-3012,037,563USD
At 2024-06-303,083,772USD
At 2024-03-313,216,119USD
At 2023-12-31-6,869,429USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-306,118,710USD
At 2024-12-3112,211,321USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-7,341,062USD92
2025-01-01 to 2025-09-30-16,177,001USD273
2025-04-01 to 2025-06-30-4,983,261USD91
2025-01-01 to 2025-03-31-3,852,678USD90
2024-07-01 to 2024-09-30-4,125,643USD92
2024-01-01 to 2024-09-30-10,328,505USD274
2024-04-01 to 2024-06-30-3,230,385USD91
2024-01-01 to 2024-03-31-2,972,477USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-13,647,893USD273
2024-01-01 to 2024-09-30-14,371,857USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-09-305,925USD273
2024-01-01 to 2024-09-3013,338USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-307,561,207USD273
2024-01-01 to 2024-09-3024,372,928USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-5,925USD273
2024-01-01 to 2024-09-30-13,338USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-126,102,121USD
At 2024-12-31-109,925,120USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-305,431,206shares92
2025-01-01 to 2025-09-304,495,724shares273
2024-07-01 to 2024-09-301,766,362shares92
2024-01-01 to 2024-09-30936,118shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-305,431,206shares92
2025-01-01 to 2025-09-304,495,724shares273
2024-07-01 to 2024-09-301,766,362shares92
2024-01-01 to 2024-09-30936,118shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1.35USD/shares92
2025-01-01 to 2025-09-30-3.6USD/shares273
2024-07-01 to 2024-09-30-2.34USD/shares92
2024-01-01 to 2024-09-30-11.03USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1.35USD/shares92
2025-01-01 to 2025-09-30-3.6USD/shares273
2024-07-01 to 2024-09-30-2.34USD/shares92
2024-01-01 to 2024-09-30-11.03USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-301,691,538USD
At 2024-12-312,104,675USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-301,137,863USD273
2024-01-01 to 2024-09-30935,135USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-5,995,835USD92
2025-01-01 to 2025-09-30-14,351,844USD273
2024-07-01 to 2024-09-30-3,282,087USD92
2024-01-01 to 2024-09-30-9,436,484USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-307,433,310USD
At 2024-12-3112,660,803USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-305,882,285USD
At 2024-12-314,972,105USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-09-30866,245USD
At 2024-12-311,270,280USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,848,544USD92
2025-01-01 to 2025-09-307,772,109USD273
2024-07-01 to 2024-09-301,428,504USD92
2024-01-01 to 2024-09-305,116,582USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-305,977,358shares
At 2024-12-313,402,306shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-09-30129,575,211USD
At 2024-12-31117,380,285USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-301,394,044USD
At 2024-12-3199,011USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-09-305,406,674USD
At 2024-12-315,400,749USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-09-303,715,136USD
At 2024-12-313,296,074USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-09-301,600,152USD
At 2024-12-311,039,625USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-09-301,295,559USD
At 2024-12-31423,157USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-7,341,062USD92
2025-01-01 to 2025-09-30-16,177,001USD273
2024-07-01 to 2024-09-30-4,125,643USD92
2024-01-01 to 2024-09-30-10,328,505USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-303,147,291USD92
2025-01-01 to 2025-09-306,579,735USD273
2024-07-01 to 2024-09-301,853,583USD92
2024-01-01 to 2024-09-304,319,902USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-07-01 to 2025-09-30106,782USD92
2025-01-01 to 2025-09-30419,062USD273
2024-07-01 to 2024-09-30165,406USD92
2024-01-01 to 2024-09-30492,788USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-573,058USD92
2025-01-01 to 2025-09-30-808,475USD273
2024-07-01 to 2024-09-3050,483USD92
2024-01-01 to 2024-09-3022,726USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-3018,695USD273
2024-01-01 to 2024-09-306,160USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-01-01 to 2025-09-307,565,637USD273
2024-01-01 to 2024-09-3024,385,615USD274

Inspect the source

Entity
Cingulate Inc. / CIK 0001862150
Captured
2026-09-21T17:31:56.019Z
SEC response SHA-256
59c430e5770a7e8cc03543e1d4bfa9a260f4983bc9e7b0469dac795e6803ef32

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001862150.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))